In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.

Firebrick Pharma Limited Balance Sheet Statement - Assets

As of 30 Jun 2025, The total current assets of Firebrick Pharma Limited (ASX:FRE) was around $1,483,747 which consisted of $983,350 of Cash, $193,981 of Inventory and $257,810 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.

All amounts in AUD

Cash
$983,350
Current assets
$1,483,747
Total assets
$1,827,648

The latest balance sheet of Firebrick Pharma Limited also showed $94,504 of Property Plant Equipment and no Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $1,827,648.

Firebrick Pharma Limited Balance Sheet Statement - Liabilities

FRE's latest annual results shows the balance sheet has $112,997 of Accounts Payable. Also there were no Short/Long term debt, no Long term debt, no Other Current liabilities and $271,276 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.

Account payable
$112,997
Current liabilities
$271,276
Total liabilities
$271,276

As per the 30 Jun 2025's annual report of Firebrick Pharma Limited, the total liabilities were $271,276.

FRE Balance Sheet Statement - Stock Holder Equity

Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.

The latest Balance sheet of Firebrick Pharma Limited showed the total stock holder equity was $1,556,372 which consisted of $19,774,509 of Common stocks, $-18,787,255 of Retained earnings and no Other stock holder equity.

FRE Balance Sheet Statement History

Following table shows the history of balance sheet for Firebrick Pharma Limited (FRE).

30 Jun 2025 30 Jun 2024 30 Jun 2023 30 Jun 2022 30 Jun 2021
Cash 983,350 824,776 2,354,579 7,142,900 -
Net Receivables 257,810 950,978 137,380 1,081,624 -
Inventory 193,981 239,769 - - -
Total Current Assets 1,483,747 2,092,162 2,589,264 8,328,332 -
Property Plant Equipment 94,504 26,806 33,851 41,755 -
Good Will - - - - -
Intangible Assets - - - - -
Other Assets - - - - -
Deferred Long Term Asset Charges - - - - -
Total Assets 1,827,648 2,406,341 2,982,459 8,729,431 -
Accounts Payable 112,997 68,902 197,484 36,271 -
Short/Long Term Debt - - - - -
Other Current Liabilities - - - - -
Long Term Debt - - - - -
Other Liabilities - - - - -
Total Current Liabilities 271,276 291,069 506,443 450,100 -
Total Liabilities 271,276 291,069 506,443 450,100 -
Common Stock 19,774,509 17,883,205 17,067,994 15,999,817 -
Retained Earnings -18,787,255 -16,512,023 -15,578,662 -8,805,100 -
Treasury Stock - - - - -
Other Stockholder Equity - - - - -
Total Stockholder Equity 1,556,372 2,115,272 2,476,016 8,279,331 -
Net Tangible Assets 1,556,372 2,115,272 2,476,016 8,279,331 -

Firebrick Pharma Limited (ASX:FRE) Balance Sheet Statement FAQ

1. How much Cash Firebrick Pharma Limited has on their balance sheet?

As of 30 Jun 2025, Firebrick Pharma Limited (ASX:FRE) has $983,350 of Cash.

2. What's the long term debt of Firebrick Pharma Limited?

As per the latest Balance sheet of Firebrick Pharma Limited (ASX:FRE), it has no Long term debt.

3. How much share holder equity does Firebrick Pharma Limited has?

The Firebrick Pharma Limited (ASX:FRE)'s balance sheet shows that it has $1,556,372 of Total stock holder equity.